LS
PAHC icon

Livforsakringsbolaget Skandia’s Phibro Animal Health PAHC Stock Holding History

Livforsakringsbolaget Skandia’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.76M Buy
+31,800
New +$1.51M 0.07% 135

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Livforsakringsbolaget Skandia's PAHC Position: Q1 2026 in Review

Livforsakringsbolaget Skandia opened a new position in Phibro Animal Health (PAHC) in Q1 2026: 31,800 shares worth $1.76M. The stake represents 0.07% of the portfolio and ranks #135 among its holdings.

257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • Livforsakringsbolaget Skandia held 31,800 shares of Phibro Animal Health worth $1.76M as of Q1 2026.
  • Phibro Animal Health was a new Livforsakringsbolaget Skandia position in Q1 2026.
  • Phibro Animal Health made up 0.07% of Livforsakringsbolaget Skandia's portfolio in Q1 2026, its #135 holding.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Livforsakringsbolaget Skandia's 13F filing for Q1 2026, filed 5 May 2026.